메뉴 건너뛰기




Volumn 29, Issue 3, 2009, Pages 321-325

Venous thrombosis in the antiphospholipid syndrome

Author keywords

2 glycoprotein I; Anticardiolipin; Antiphospholipid; Lupus anticoagulant; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PHOSPHOLIPID BINDING PROTEIN; PLACEBO; PROTHROMBIN; WARFARIN;

EID: 61549121383     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.108.182204     Document Type: Article
Times cited : (60)

References (59)
  • 2
    • 0036228886 scopus 로고    scopus 로고
    • Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, De Groot Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quere I, Hachulla E, Vasconcelos C, Roch B, Fernandez-Nebro A, Boffa MC, Hughes GR, Ingelmo M. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019-1027.
    • Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, De Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quere I, Hachulla E, Vasconcelos C, Roch B, Fernandez-Nebro A, Boffa MC, Hughes GR, Ingelmo M. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019-1027.
  • 5
    • 0033887692 scopus 로고    scopus 로고
    • Antiphospholipid syndrome: Antibodies and antigens
    • Roubey RA. Antiphospholipid syndrome: antibodies and antigens. Curr Opin Hematol. 2000;7:316-320.
    • (2000) Curr Opin Hematol , vol.7 , pp. 316-320
    • Roubey, R.A.1
  • 6
    • 42949144324 scopus 로고    scopus 로고
    • Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members
    • Maiti SN, Balasubramanian K, Ramoth JA, Schroit AJ. Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members. J Biol Chem. 2008;283:3761-3766.
    • (2008) J Biol Chem , vol.283 , pp. 3761-3766
    • Maiti, S.N.1    Balasubramanian, K.2    Ramoth, J.A.3    Schroit, A.J.4
  • 8
    • 1642399591 scopus 로고    scopus 로고
    • Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: Loss of inhibition by clipped beta 2-glycoprotein I
    • Shi T, Iverson GM, Qi JC, Cockerill KA, Linnik MD, Konecny P, Krilis SA. Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I. Proc Natl Acad Sci U S A. 2004;101:3939-3944.
    • (2004) Proc Natl Acad Sci U S A , vol.101 , pp. 3939-3944
    • Shi, T.1    Iverson, G.M.2    Qi, J.C.3    Cockerill, K.A.4    Linnik, M.D.5    Konecny, P.6    Krilis, S.A.7
  • 10
    • 0030457493 scopus 로고    scopus 로고
    • Lupus anticoagulant in the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus: Comparison between different assays for the detection of antiphospholipid antibodies
    • Horbach DA, Oort EV, Bonders RCJM, Derksen RHWM, De Groot PG. Lupus anticoagulant in the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus: comparison between different assays for the detection of antiphospholipid antibodies. Thromb Haemost. 1996;76:916-924.
    • (1996) Thromb Haemost , vol.76 , pp. 916-924
    • Horbach, D.A.1    Oort, E.V.2    Bonders, R.C.J.M.3    Derksen, R.H.W.M.4    De Groot, P.G.5
  • 11
    • 0030779955 scopus 로고    scopus 로고
    • Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus-a meta-analysis
    • Wahl DG, Guillemin F, de ME, Perret C, Lecompte T, Thibaut G. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus-a meta-analysis. Lupus. 1997;6:467-473.
    • (1997) Lupus , vol.6 , pp. 467-473
    • Wahl, D.G.1    Guillemin, F.2    de, M.E.3    Perret, C.4    Lecompte, T.5    Thibaut, G.6
  • 12
    • 32544444877 scopus 로고    scopus 로고
    • Cervera R, barca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, Bacarelli MR, Bellisai F, Bernardino I, Biernat-Kaluza E, Blockmans D, Boki K, Bracci L, Campanella V, Camps MT, Carcassi C, Cattaneo R, Cauli A, Cervera R, Chwalinska-Sadowska H, Contu L, Cosyns JP, Danieli MG, DCruz D, Depresseux G, Direskeneli H, Domenech I, Espinosa G, Fernandez-Nebro A, Ferrara GB, Font J, Frutos MA, Galeazzi M, Garcia-Carrasco M, Garcia Iglesias MF, Garcia-Tobaruela A, George J, Gil A, Gonzalez-Santos P, Grana M, Gul A, Haga HJ, de Haro-Liger M, Houssiau F, Hughes GR, Ingelmo M. Jedryka-Goral A, Khamashta MA, Lavilla P, Levi Y, Lopez-Dulpa M, Lopez-Soto A, Maldykowa H, Marcolongo R, Mathieu A, Morozzi G, Nicolopoulou N, Papasteriades C, Passiu G, Perello I, Petera P, Petrovic R, Piette JC, Pintado V, de PO, Popovic R, Pucci G, Puddu P, de RE, Ramos-Casals M, Rodriguez-Andreu J, Ruiz-Irastorza G, Sanchez-Lora J, Sanna G, Scorza R, Sebastiani GD, Sherer Y, Shoenfeld Y, Simpatico A, Si
    • Cervera R, barca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, Bacarelli MR, Bellisai F, Bernardino I, Biernat-Kaluza E, Blockmans D, Boki K, Bracci L, Campanella V, Camps MT, Carcassi C, Cattaneo R, Cauli A, Cervera R, Chwalinska-Sadowska H, Contu L, Cosyns JP, Danieli MG, DCruz D, Depresseux G, Direskeneli H, Domenech I, Espinosa G, Fernandez-Nebro A, Ferrara GB, Font J, Frutos MA, Galeazzi M, Garcia-Carrasco M, Garcia Iglesias MF, Garcia-Tobaruela A, George J, Gil A, Gonzalez-Santos P, Grana M, Gul A, Haga HJ, de Haro-Liger M, Houssiau F, Hughes GR, Ingelmo M. Jedryka-Goral A, Khamashta MA, Lavilla P, Levi Y, Lopez-Dulpa M, Lopez-Soto A, Maldykowa H, Marcolongo R, Mathieu A, Morozzi G, Nicolopoulou N, Papasteriades C, Passiu G, Perello I, Petera P, Petrovic R, Piette JC, Pintado V, de PO, Popovic R, Pucci G, Puddu P, de RE, Ramos-Casals M, Rodriguez-Andreu J, Ruiz-Irastorza G, Sanchez-Lora J, Sanna G, Scorza R, Sebastiani GD, Sherer Y, Shoenfeld Y, Simpatico A, Sinico RA, Smolen J, Tincani A, Tokgoz G, Urbano-Marquez A, Vasconcelos C, Vazquez JJ, Veronesi J, Vianna J, Vivancos J. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev. 2006;5:180-186.
  • 13
    • 22244470734 scopus 로고    scopus 로고
    • Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients
    • Calvo-Alen J, Toloza SM, Femandez M, Bastian HM, Fessier BJ, Roseman JM, McGwin G Jr, Vila LM, Reveille JD, Alarcon GS. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum. 2005;52:2060-2068.
    • (2005) Arthritis Rheum , vol.52 , pp. 2060-2068
    • Calvo-Alen, J.1    Toloza, S.M.2    Femandez, M.3    Bastian, H.M.4    Fessier, B.J.5    Roseman, J.M.6    McGwin Jr, G.7    Vila, L.M.8    Reveille, J.D.9    Alarcon, G.S.10
  • 14
    • 0037370733 scopus 로고    scopus 로고
    • Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature
    • Galli M, Luciani D, Bertolini G, Barbui T, Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101:1827-1832.
    • (2003) Blood , vol.101 , pp. 1827-1832
    • Galli, M.1    Luciani, D.2    Bertolini, G.3    Barbui, T.4
  • 15
    • 0031982693 scopus 로고    scopus 로고
    • Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis
    • Wahl DG, Guillemin F, de ME, Perret-Guillaume C, Lecompte T, Thibaut G. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus. 1998;7:15-22.
    • (1998) Lupus , vol.7 , pp. 15-22
    • Wahl, D.G.1    Guillemin, F.2    de, M.E.3    Perret-Guillaume, C.4    Lecompte, T.5    Thibaut, G.6
  • 16
    • 33644869517 scopus 로고    scopus 로고
    • A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)
    • Naess IA, Christiansen SC, Cannegieter SC, Rosendaal FR, Hammerstroem J. A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study). J Thromb Haemost. 2006;4:44-49.
    • (2006) J Thromb Haemost , vol.4 , pp. 44-49
    • Naess, I.A.1    Christiansen, S.C.2    Cannegieter, S.C.3    Rosendaal, F.R.4    Hammerstroem, J.5
  • 17
    • 0036454495 scopus 로고    scopus 로고
    • Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study
    • Runchey SS, Folsom AR, Tsai MY, Cushman M, McGovern PD. Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study. Br J Haematol. 2002;119:1005-1010.
    • (2002) Br J Haematol , vol.119 , pp. 1005-1010
    • Runchey, S.S.1    Folsom, A.R.2    Tsai, M.Y.3    Cushman, M.4    McGovern, P.D.5
  • 18
    • 84941817790 scopus 로고
    • Thrombosis, recurrent fetal loss, thrombocytopenia: Predictive value of IgG anticardiolipin antibodies
    • Harris EN, Chan JKH, Asherson RA, Aber VA, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, thrombocytopenia: predictive value of IgG anticardiolipin antibodies. Arch Intern Med. 1986;146: 2153-2156.
    • (1986) Arch Intern Med , vol.146 , pp. 2153-2156
    • Harris, E.N.1    Chan, J.K.H.2    Asherson, R.A.3    Aber, V.A.4    Gharavi, A.E.5    Hughes, G.R.V.6
  • 19
    • 34347249882 scopus 로고    scopus 로고
    • Assessment of the 2006 revised antiphospholipid syndrome classification criteria
    • Kaul M, Erkan D, Sammaritano L, Lockshin MD. Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2007;66:927-930.
    • (2007) Ann Rheum Dis , vol.66 , pp. 927-930
    • Kaul, M.1    Erkan, D.2    Sammaritano, L.3    Lockshin, M.D.4
  • 20
    • 3042787713 scopus 로고    scopus 로고
    • The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus
    • Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der MJ. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood. 2004; 104:143-148.
    • (2004) Blood , vol.104 , pp. 143-148
    • Brouwer, J.L.1    Bijl, M.2    Veeger, N.J.3    Kluin-Nelemans, H.C.4    van der, M.J.5
  • 21
    • 0242693145 scopus 로고    scopus 로고
    • The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies
    • Hudson M, Herr AL, Rauch J, Neville C, Chang E, Ibrahim R, Seguin C, Kassis J, Busque L, Fortin PR. The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies. J Rheumatol. 2003;30:2385-2391.
    • (2003) J Rheumatol , vol.30 , pp. 2385-2391
    • Hudson, M.1    Herr, A.L.2    Rauch, J.3    Neville, C.4    Chang, E.5    Ibrahim, R.6    Seguin, C.7    Kassis, J.8    Busque, L.9    Fortin, P.R.10
  • 23
    • 0028787634 scopus 로고
    • Induction of thrombosis in a mouse model by IgG, IgM, and IgA immunoglobulins from patients with the antiphospholipid syndrome
    • Pierangeli SS, Liu XW, Barker JH, Anderson G, Harris EN. Induction of thrombosis in a mouse model by IgG, IgM, and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost. 1995;74:1361-1367.
    • (1995) Thromb Haemost , vol.74 , pp. 1361-1367
    • Pierangeli, S.S.1    Liu, X.W.2    Barker, J.H.3    Anderson, G.4    Harris, E.N.5
  • 25
    • 0035793334 scopus 로고    scopus 로고
    • Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin
    • Pierangeli SS, Espinola RG, Liu X, Harris EN. Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circ Res. 2001;88:245-250.
    • (2001) Circ Res , vol.88 , pp. 245-250
    • Pierangeli, S.S.1    Espinola, R.G.2    Liu, X.3    Harris, E.N.4
  • 26
    • 22244485396 scopus 로고    scopus 로고
    • Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia
    • Pierangeli SS, Girardi G, Vega-Ostertag M, Liu X, Espinola RG, Salmon J. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum. 2005;52: 2120-2124.
    • (2005) Arthritis Rheum , vol.52 , pp. 2120-2124
    • Pierangeli, S.S.1    Girardi, G.2    Vega-Ostertag, M.3    Liu, X.4    Espinola, R.G.5    Salmon, J.6
  • 29
    • 0025001363 scopus 로고
    • Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies
    • Malia RG, Kitchen S, Greaves M, Preston FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol. 1990;76:101-107.
    • (1990) Br J Haematol , vol.76 , pp. 101-107
    • Malia, R.G.1    Kitchen, S.2    Greaves, M.3    Preston, F.E.4
  • 30
    • 0033404817 scopus 로고    scopus 로고
    • The putative mechanism of thrombosis in antiphospholipid syndrome: Impairment of the protein C and the fibrinolytic systems by monoclonal anticardiolipin antibodies
    • Ieko M, Sawada KI, Koike T, Notoya A, Mukai M, Kohno M, Wada N, Itoh T, Yoshioka N. The putative mechanism of thrombosis in antiphospholipid syndrome: impairment of the protein C and the fibrinolytic systems by monoclonal anticardiolipin antibodies. Semin Thromb Hemost. 1999;25:503-507.
    • (1999) Semin Thromb Hemost , vol.25 , pp. 503-507
    • Ieko, M.1    Sawada, K.I.2    Koike, T.3    Notoya, A.4    Mukai, M.5    Kohno, M.6    Wada, N.7    Itoh, T.8    Yoshioka, N.9
  • 31
    • 57149100983 scopus 로고    scopus 로고
    • Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C
    • de LB, Eckmann CM, van SM, Meijer AB, Mertens K, Van Mourik JA. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C. Blood Coagul Fibrinolysis. 2008;19:757-764.
    • (2008) Blood Coagul Fibrinolysis , vol.19 , pp. 757-764
    • de, L.B.1    Eckmann, C.M.2    van, S.M.3    Meijer, A.B.4    Mertens, K.5    Van Mourik, J.A.6
  • 32
    • 59649088107 scopus 로고    scopus 로고
    • Tissue factor in the antiphospholipid syndrome
    • Kinev AV, Roubey RA. Tissue factor in the antiphospholipid syndrome. Lupus. 2008;17:952-958.
    • (2008) Lupus , vol.17 , pp. 952-958
    • Kinev, A.V.1    Roubey, R.A.2
  • 33
    • 34250158455 scopus 로고    scopus 로고
    • The tissue factor-factor Vila complex: Procoagulant activity, regulation, and multitasking
    • Monroe DM, Key NS. The tissue factor-factor Vila complex: procoagulant activity, regulation, and multitasking. J Thromb Haemost. 2007; 5:1097-1105.
    • (2007) J Thromb Haemost , vol.5 , pp. 1097-1105
    • Monroe, D.M.1    Key, N.S.2
  • 34
    • 3242697048 scopus 로고    scopus 로고
    • Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep
    • Zhou H, Wolberg AS, Roubey RAS. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood. 2004;104:2353-2358.
    • (2004) Blood , vol.104 , pp. 2353-2358
    • Zhou, H.1    Wolberg, A.S.2    Roubey, R.A.S.3
  • 35
    • 0031886679 scopus 로고    scopus 로고
    • The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome
    • Amengual O, Atsumi T, Khamashta MA, Hughes GRV. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost. 1998;79:276-281.
    • (1998) Thromb Haemost , vol.79 , pp. 276-281
    • Amengual, O.1    Atsumi, T.2    Khamashta, M.A.3    Hughes, G.R.V.4
  • 37
    • 18644361988 scopus 로고    scopus 로고
    • Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies
    • Vega-Ostertag M, Casper K, Swerlick R, Ferrara D, Harris EN, Pierangeli SS. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum. 2005; 52:1545-1554.
    • (2005) Arthritis Rheum , vol.52 , pp. 1545-1554
    • Vega-Ostertag, M.1    Casper, K.2    Swerlick, R.3    Ferrara, D.4    Harris, E.N.5    Pierangeli, S.S.6
  • 40
    • 0032700453 scopus 로고    scopus 로고
    • Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome
    • Dobado-Berrios PM, Lopez-Pedrera C, Velasco F, Aguirre MA, Torres A, Cuadrado MJ. Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome. Thromb Haemost. 1999;82:1578-1582.
    • (1999) Thromb Haemost , vol.82 , pp. 1578-1582
    • Dobado-Berrios, P.M.1    Lopez-Pedrera, C.2    Velasco, F.3    Aguirre, M.A.4    Torres, A.5    Cuadrado, M.J.6
  • 41
    • 0029911062 scopus 로고    scopus 로고
    • Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein S
    • Reverter JC, Tassies D, Font J, Monteagudo J, Escolar G, Ingelmo M, Ordinas A. Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein S. Arterioscler Thromb Vasc Biol. 1996;16:1319-1326.
    • (1996) Arterioscler Thromb Vasc Biol , vol.16 , pp. 1319-1326
    • Reverter, J.C.1    Tassies, D.2    Font, J.3    Monteagudo, J.4    Escolar, G.5    Ingelmo, M.6    Ordinas, A.7
  • 46
  • 47
    • 37349061734 scopus 로고    scopus 로고
    • A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies
    • Ruiz-Irastorza G, Hunt BJ, Khamashta MA. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Care Res. 2007;57:1487-1495.
    • (2007) Arthritis Care Res , vol.57 , pp. 1487-1495
    • Ruiz-Irastorza, G.1    Hunt, B.J.2    Khamashta, M.A.3
  • 48
    • 0031203621 scopus 로고    scopus 로고
    • Monitoring warfarin therapy in patients with lupus anticoagulants
    • Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med. 1997;127:177-185.
    • (1997) Ann Intern Med , vol.127 , pp. 177-185
    • Moll, S.1    Ortel, T.L.2
  • 49
    • 6744257508 scopus 로고    scopus 로고
    • Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant
    • Sanfelippo MJ, Sennet J, McMahon EJ. Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant. WMJ. 2000;99: 62-64.
    • (2000) WMJ , vol.99 , pp. 62-64
    • Sanfelippo, M.J.1    Sennet, J.2    McMahon, E.J.3
  • 50
    • 3042701142 scopus 로고    scopus 로고
    • Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant
    • Rosborough TK, Shepherd MF. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant. Pharmacotherapy. 2004;24:838-842.
    • (2004) Pharmacotherapy , vol.24 , pp. 838-842
    • Rosborough, T.K.1    Shepherd, M.F.2
  • 51
    • 37349096325 scopus 로고    scopus 로고
    • Warfarin and the antiphospholipid syndrome: Does one size fit all?
    • Kasthuri RS, Roubey RA. Warfarin and the antiphospholipid syndrome: does one size fit all? Arthritis Rheum. 2007;57:1346-1347.
    • (2007) Arthritis Rheum , vol.57 , pp. 1346-1347
    • Kasthuri, R.S.1    Roubey, R.A.2
  • 52
    • 0038053217 scopus 로고    scopus 로고
    • Antiphospholipid antibodies and thrombosis: Strength of association
    • Galli M, Barbui T. Antiphospholipid antibodies and thrombosis: strength of association. Hematol J. 2003;4:180-186.
    • (2003) Hematol J , vol.4 , pp. 180-186
    • Galli, M.1    Barbui, T.2
  • 53
    • 0027203896 scopus 로고
    • Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment
    • Derksen RHWM, De Groot PG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis. 1993;52:689-692.
    • (1993) Ann Rheum Dis , vol.52 , pp. 689-692
    • Derksen, R.H.W.M.1    De Groot, P.G.2    Kater, L.3    Nieuwenhuis, H.K.4
  • 55
    • 38049059906 scopus 로고    scopus 로고
    • Rituximab effectively reverses papilledema associated with cerebral venous sinus thrombosis in antiphospholipid antibody syndrome
    • Chalam KV, Gupta SK, Agarwal S. Rituximab effectively reverses papilledema associated with cerebral venous sinus thrombosis in antiphospholipid antibody syndrome. Eur J Ophthalmol. 2007;17:867-870.
    • (2007) Eur J Ophthalmol , vol.17 , pp. 867-870
    • Chalam, K.V.1    Gupta, S.K.2    Agarwal, S.3
  • 56
    • 61949133655 scopus 로고    scopus 로고
    • Clinical improvement in antiphospholipid syndrome after rituximab therapy
    • Adamson R, Sangle S, Kaul A, Hughes GR, D'Cruz DP. Clinical improvement in antiphospholipid syndrome after rituximab therapy. J Clin Rheumatol. 2008;14:359-360.
    • (2008) J Clin Rheumatol , vol.14 , pp. 359-360
    • Adamson, R.1    Sangle, S.2    Kaul, A.3    Hughes, G.R.4    D'Cruz, D.P.5
  • 57
    • 34547407889 scopus 로고    scopus 로고
    • Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals
    • Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L, Unalp-Arida A, Vilela V, Yazici Y, Lockshin MD. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 2007;56:2382-2391.
    • (2007) Arthritis Rheum , vol.56 , pp. 2382-2391
    • Erkan, D.1    Harrison, M.J.2    Levy, R.3    Peterson, M.4    Petri, M.5    Sammaritano, L.6    Unalp-Arida, A.7    Vilela, V.8    Yazici, Y.9    Lockshin, M.D.10
  • 58
    • 0029990745 scopus 로고    scopus 로고
    • Hydroxychloroquine use in the Baltimore Lupus Cohort: Effects on lipids, glucose and thrombosis
    • Petri M. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus. 1996;5:S16-S22.
    • (1996) Lupus , vol.5
    • Petri, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.